Delivery Order SPE2DB20D3101-SPE2DB24FRRU1
Award Date
8/7/24
Potential Completion Date
8/8/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,565,843,623 units of Methotrexate 2.5 mg tablets. The $3,853.16 firm fixed-price award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of September 18, 2024 and does not use a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Methotrexate 2.5 mg tablets. The $1,383.08 firm fixed-price delivery order has a completion date of December 30, 2022 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $1,563.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of 4,565,634,382 units of Methotrexate 2.5 mg tablets. The contract has a completion date of August 30, 2024 and is a Firm Fixed Price Delivery Order. This contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and...
This federal contract award is a delivery order (SPE2DB20D1100|SPE2DB25FY70K) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,174.36 firm-fixed-price contract is for the delivery of Methotrexate 2.5 mg tablets, a medication used to treat various conditions. The contract has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $3,971.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,143,768 units of methotrexate 2.5 mg tablets, a medication used to treat various medical conditions. The contract is a firm-fixed-price delivery order with a performance period extending through May 6, 2025. Amerisourcebergen Drug Corp is also the holder of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Methotrexate 2.5 mg tablets. The contract, valued at $2,294.28, is a firm-fixed-price delivery order with an ultimate completion date of August 9, 2024. Amerisourcebergen, through its corporate office division, will provide these pharmaceutical products to support federal healthcare programs and military treatment facilities. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Methotrexate 2.5 mg tablets. The delivery order has a ceiling value of $1,906.78 and an ultimate completion date of September 11, 2024. The contract is a firm-fixed price type. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to provide the specified medication to support the healthcare needs of military treatment facilities and other...
This is a $3,175.20 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Methotrexate 1 gram/40 ml vials, with a period of performance through June 17, 2025. The award is not set aside and is a firm fixed-price contract. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of METHOTREXATE 2.5 MG TABLET 100S. The contract has a ceiling value of $8,542.21 and is a Firm Fixed Price Delivery Order with a performance period ending on May 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
The Defense Logistics Agency awarded a delivery order valued at approximately $1,098 to Amerisourcebergen Drug Corporation for the supply of 100 units of 2.5 mg methotrexate tablets. The order was placed under an existing prime vendor contract held by Amerisourcebergen with DLA to provide pharmaceutical products and services in support of DOD missions. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of four days from July 21 through July 24,...